News Novo hopes data will boost new insulin in US and Germany Novo Nordisk hopes that new data supporting the cardiovascular and glycaemic safety of its Tresiba long-acting insulin will prove a game-changer in the US.
News Pharma hires Theresa May's former adviser to head government... Saratha Rajeswaran will lead government affairs team
News FDA's Gottlieb reveals plans to tackle generic price abuses Tackling high drug prices is priority for Trump administrations.
News UK watchdog says MSD may have blocked Remicade biosimilars MSD may have abused dominant market position, says CMA.
News EU probes Aspen price gouging allegations Aspen pulled drugs from some countries that rejected price hikes, says EU.
News US authorities probe marketing of J&J drugs US authorities suspicious over marketing, rebates and payment support programmes.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.